Literature DB >> 26548607

UHRF1 promotes human osteosarcoma cell invasion by downregulating the expression of E‑cadherin in an Rb1‑dependent manner.

Wei Liu1, Rui Hong Qiao1, Dong Ming Wang1, Xiao Wei Huang2, Bing Li1, Dong Wang1.   

Abstract

Ubiquitin‑like with plant homeodomain (PHD) and RING‑finger domain 1 (UHRF1) maintains methylation patterns following DNA replication and is expressed at high levels in various types of human cancer. UHRF1 has been identified as a novel oncogene involved in the pathogenesis of hepatocellular carcinoma. Previous studies have demonstrated that inhibition of the expression of UHRF1 suppresses the proliferation of cancer cells. However, the role of UHRF1 in human osteosarcoma has not been investigated. The present study examined the expression levels of UHRF1 and retinoblastoma 1 (Rb1) in human osteosarcoma cell lines by western blot analysis. Stable overexpression of UHRF1 or knockdown of Rb1 was achieved by lentiviral transfection. Subsequently, a Cell Counting Kit-8 assay and a cell invasion assay were performed to detect the biological functions of UHRF1 in vitro. The results of the present study demonstrated that UHRF1 promoted the proliferation of human osteosarcoma cells. The present study also reported that UHRF1 was able to enhance the invasion of osteosarcoma cells in a retinoblastoma 1 (Rb1)‑dependent manner. UHRF1 promoted invasion in Rb1‑positive osteosarcoma cells, but not in Saos‑2 cells with homozygous loss of Rb1. Similarly, knockdown of Rb1 in Rb1‑positive osteosarcoma cells enhanced levels of invasion and eliminated the regulation of invasion by UHRF1. UHRF1 was found to inhibit the mRNA and protein expression levels of Rb1. Furthermore, deletion of Rb1 was found to suppress the expression of E‑cadherin and promote epithelial‑to‑mesenchymal transition (EMT). In addition, the overexpression of UHRF1 inhibited the expression of E‑cadherin and promoted EMT via the suppression of Rb1. These data demonstrated that UHRF1 promotes osteosarcoma cell invasion by downregulating the expression of E‑cadherin and increasing EMT in an Rb1‑dependent manner.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26548607     DOI: 10.3892/mmr.2015.4515

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  UHRF1 promotes breast cancer progression by suppressing KLF17 expression by hypermethylating its promoter.

Authors:  Shui-Ping Gao; He-Fen Sun; Liang-Dong Li; Wen-Yan Fu; Wei Jin
Journal:  Am J Cancer Res       Date:  2017-07-01       Impact factor: 6.166

Review 2.  Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer.

Authors:  Mahmoud Alhosin; Ziad Omran; Mazin A Zamzami; Abdulrahman L Al-Malki; Hani Choudhry; Marc Mousli; Christian Bronner
Journal:  J Exp Clin Cancer Res       Date:  2016-11-14

Review 3.  The role of ubiquitination and deubiquitination in the regulation of cell junctions.

Authors:  Junting Cai; Miranda K Culley; Yutong Zhao; Jing Zhao
Journal:  Protein Cell       Date:  2017-10-27       Impact factor: 14.870

4.  Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma.

Authors:  Jinpo Yang; Anran Zhang; Huan Luo; Chao Ma
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.996

5.  UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK/SEMA3E suppression.

Authors:  Stephanie C Wu; Ahhyun Kim; Yijun Gu; Daniel I Martinez; Loredana Zocchi; Claire C Chen; Jocelyne Lopez; Kelsey Salcido; Sarah Singh; Jie Wu; Ali Nael; Claudia A Benavente
Journal:  Oncogenesis       Date:  2022-09-06       Impact factor: 6.524

6.  Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis.

Authors:  Lin Xie; Zhihong Yao; Ya Zhang; Dongqi Li; Fengdi Hu; Yedan Liao; Ling Zhou; Yonghong Zhou; Zeyong Huang; Zewei He; Lei Han; Yihao Yang; Zuozhang Yang
Journal:  Cell Death Dis       Date:  2018-07-10       Impact factor: 8.469

7.  Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner.

Authors:  Lucia Tombolan; Elisabetta Rossi; Angelica Zin; Luisa Santoro; Paolo Bonvini; Rita Zamarchi; Gianni Bisogno
Journal:  Transl Oncol       Date:  2020-08-14       Impact factor: 4.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.